Srihari S. Naidu, M.D., FACC, FAHA, FSCAI, is triple board-certified in internal medicine, cardiology, and interventional cardiology, and has been featured in Westchester Magazine and on the cover of Cardiovascular Business, both of which highlighted his national role in hypertrophic cardiomyopathy, the most common cause of sudden cardiac death in athletes and a common cause of heart failure. Dr. Naidu is a pioneer in the minimally-invasive alternative to open heart surgery known as alcohol septal ablation and performs the highest volume annually of this procedure in the United States.

He began his career as an attending at New York Presbyterian – Cornell and New York University Winthrop, before joining the faculty at New York Medical College and Westchester Medical Center, where he directs both the Hypertrophic Cardiomyopathy (HCM) National Center of Excellence and the cardiac catheterization laboratories for the network.

The HCM Center at Westchester Medical Center is one of the ten busiest in the nation, treating thousands of patients with this disease.  Dr. Naidu edits the only comprehensive textbook, Hypertrophic Cardiomyopathy (Springer, Inc.), launching its third edition, and also runs an annual live proctoring course for others interested in learning the technique and bringing it back to their hospital.

Dr. Naidu is also an expert in cardiogenic shock and mechanical support devices to help the failing heart. In 2019, he chaired the writing group on a new universal definition of cardiogenic shock that has become the standard across the world, and he has been instrumental in both developing technologies for cardiogenic shock and validating the definition.

Dr. Naidu has more than 200 original manuscripts, book chapters, and review articles, and lectures widely across the United States, Europe, and Asia on his topics of expertise.  A regularly invited speaker at the American Heart Association (AHA) and the American College of Cardiology (ACC), he has chaired several national guidelines and consensus documents on behalf of both organizations. 

Dr. Naidu holds several national professional roles and is currently president of the New York Chapter of the ACC representing all cardiologists within the State and sits on the Board of Governors of the National ACC in Washington, DC.

He has also served as past trustee of the Society for Cardiovascular Angiography and Interventions (SCAI) and will take on the role of president from 2025 to 2026 leading the field of interventional cardiology. In New York State, he is a member of the Cardiac Advisory Council, appointed by Governor Kathy Hochul.  He is also active at his alma mater Brown University as trustee emeritus of the University and past president of its Medical School Board.

Education

• B.S., Neuroscience, Brown University
• M.D., The Warren Alpert Medical School, Brown University
• Residency: Internal Medicine, New York Presbyterian Hospital – Cornell Medical Center
• Fellowships: Cardiology and Interventional Cardiology, University of Pennsylvania

Publications

• Desai MY, Okushi Y, Wolski K, et. al. "Mavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM: Insights From the VALOR-HCM Trial." JACC. Cardiovascular imaging, (), (2024) . pii: S1936-878X(24)00345-0. doi: 10.1016/j.jcmg.2024.08.005
• Desai MY, Owens A, Wolski K, et. al. "Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction: Health Status Analysis Through Week 56 in VALOR-HCM Trial." Journal of the American College of Cardiology, 84(11), (2024) 1041-1045. doi: 10.1016/j.jacc.2024.06.025
• Desai MY, Okushi Y, Gaballa A, et. al. "Serial Changes in Ventricular Strain in Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten: Insights From the VALOR-HCM Trial." Circulation. Cardiovascular imaging, 17(9), (2024) e017185. doi: 10.1161/CIRCIMAGING.124.017185
• Sandoval Y, Cigarroa JE, Dangas GD, et. al. "Coronary Microvascular Dysfunction." Journal of the Society for Cardiovascular Angiography & Interventions, 3(3Part A), (2023) 101230. doi: 10.1016/j.jscai.2023.101230
• Marshall JJ, Ashwath ML, Jefferies JL, et. al. "Restrictive Covenants and Noncompete Clauses for Physicians." JACC. Advances, 2(7), (2023) 100547. doi: 10.1016/j.jacadv.2023.100547
• Zhu M, Reyes KRL, Bilgili G, et. al. "Medical Therapies to Improve Left Ventricular Outflow Obstruction and Diastolic Function in Hypertrophic Cardiomyopathy." JACC. Advances, 2(8), (2023) 100622. doi: 10.1016/j.jacadv.2023.100622
• Writing Committee Members, Ommen SR, Ho CY, et. al. "2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines." Journal of the American College of Cardiology, 83(23), (2024) 2324-2405. doi: 10.1016/j.jacc.2024.02.014

View All Publications

Memberships and Affiliations

• Past Trustee, Society for Cardiovascular Angiography and Interventions (SCAI)
• Trustee Emeritus, Brown University
• Past President, Brown University Medical School Board of Directors
• President-Elect, New York Chapter of the ACC